Literature DB >> 22342898

Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.

J E Cornick1, S D Bentley.   

Abstract

Multi drug resistant Streptococcus pneumoniae constitute a major public health concern worldwide. In this review we discuss how the transformable nature of the pneumococcus, in parallel with antimicrobial induced stress, contributes to the evolution of antimicrobial resistance; and how the introduction of the pneumococcal conjugate vaccine has affected the situation.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22342898     DOI： 10.1016/j.micinf.2012.01.012

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  36 in total

Review 1.  Evolving resistance among Gram-positive pathogens.

Authors:  Jose M Munita; Arnold S Bayer; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2015-09-15       Impact factor: 9.079

2.  Unveiling the Importance of Amide Protons in CSP:ComD Interactions in Streptococcus pneumoniae.

Authors:  Bimal Koirala; Naiya R Phillips; Yftah Tal-Gan
Journal:  ACS Med Chem Lett       Date:  2019-04-30       Impact factor: 4.345

Review 3.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  In Vitro Activity of Lascufloxacin against Streptococcus pneumoniae with Mutations in the Quinolone Resistance-Determining Regions.

Authors:  Mika Murata; Kosuke Kosai; Shunsuke Yamauchi; Daisuke Sasaki; Norihito Kaku; Naoki Uno; Yoshitomo Morinaga; Hiroo Hasegawa; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Mukae; Katsunori Yanagihara
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.

Authors:  Kelli Metzler; Karl Drlica; Joseph M Blondeau
Journal:  J Antimicrob Chemother       Date:  2012-11-20       Impact factor: 5.790

6.  Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!

Authors:  Hiba Sabbar; Chafik Mahraoui; Magdalena Bastìas Garcià; Imane Jroundi
Journal:  Vaccine X       Date:  2022-05-14

7.  Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.

Authors:  I Lysnyansky; I Gerchman; I Mikula; F Gobbo; S Catania; S Levisohn
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

Review 8.  One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.

Authors:  Dustin T King; Solmaz Sobhanifar; Natalie C J Strynadka
Journal:  Protein Sci       Date:  2016-03-09       Impact factor: 6.725

Review 9.  Mechanisms and impact of genetic recombination in the evolution of Streptococcus pneumoniae.

Authors:  Chrispin Chaguza; Jennifer E Cornick; Dean B Everett
Journal:  Comput Struct Biotechnol J       Date:  2015-04-08       Impact factor: 7.271

10.  Sensitivity Patterns of Bacterial Pathogens Isolated from Blood Cultures of Under-Five Children with Pneumonia and Clinical Sepsis.

Authors:  Sufia Islam; Ashiqur Rahman Akand; Tasnova Tasnim Nova; Christian Lehmann; Mohammod Jobayer Chisti
Journal:  Life (Basel)       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.